Fresenius (FSNUF.PK, FSNPF.PK) said it has delivered a strong final quarter and fully met targets for the year. Fourth quarter EBIT before special items was 1.17 billion euros, down 7%, or a decline of 9% in constant currency. The company said the decline in EBIT before special items is primarily due to COVID-19 related headwinds at Fresenius Medical Care.
from RTT - Earnings https://ift.tt/K2aBCbq
via IFTTT
No comments:
Post a Comment